Page last updated: 08 July 2022

Laboratories seeking eligibility for Medical Benefit rebates for pathology services are expected to meet the specified quality standards specified in the Health Insurance (Accredited Pathology Laboratories-Approval) Principles 2017.

One of the key responsibilities of NPAAC is the development and maintenance of accreditation standards and guidelines for pathology laboratories. Accreditation assessment for laboratories are performed by the National Association of Testing Authorities, Australia (NATA) in accordance with the specified quality standards.

Pathology Accreditation Assessments in 2022

The following advice on pathology accreditation processes during the continued response to the COVID is provided for guidance.

Pathology accreditation assessments in 2022

Accreditation Requirements for SARS-CoV-2 Testing

Laboratories performing SARS-CoV-2 testing must be specifically accredited for SARS-CoV-2 testing in order to be eligible for Medicare rebates.

Laboratories performing SARS-CoV-2 testing are expected to contact to NATA to confirm their accreditation status.

Accreditation requirements for SARS-CoV-2 Testing (PDF 97 KB)
Accreditation requirements for SARS-CoV-2 Testing (Word 145 KB)

Guidelines for COVID-19 Temporary Collection Facilities (Drive through and Pop-up)

As part of the response to the COVID-19 pandemic, temporary collection facilities have been established by either state/ territory governments or laboratory providers for the collection of specimens from patients. This is with the aim of providing more access to collection services that will enable more testing for COVID to occur.

To support the temporary COVID collection facilities, guidance is provided with the aim of reducing any potential risks to patients and aimed at ensuing quality pathology results.

COVID Point of Care Testing

Refer to NPAAC Advisory Notes.

For any queries, please contact the Department of Health and Aged Care